Contact WAO | e-News Sign Up | Site Map | Home  
World Allergy Organization
WAO's mission: To be a global resource and advocate in the field of allergy, advancing excellence in clinical care through education, research and training as a world-wide alliance of allergy and clinical immunology societies.

Life-Threatening Allergy An Homage to Von Pirquet

Epidemiology of Anaphylaxis


Aziz Sheikh, BSc, MBBS, MSc, MD, MRCP, DCH, DRCOG, DFFP, FRCGP
The University of Edinburgh
Edinburgh, Scotland

Aziz Sheikh is Professor of Primary Care Research and Development, Department of General Practice, University of Edinburgh. Prof. Sheikh is a member of the Working Party on Epidemiology of Anaphylaxis of the American Academy of Allergy, Asthma and Immunology, and a member of the British Thoracic Society Research Committee. He holds a Masters degree in Epidemiology. Prof. Sheikh’s research interests include evaluating the clinical effectiveness of established and new treatments for use in primary care, and investigating the epidemiology and clinical management of asthma and other allergic disorders.

Abstract

Characterizing the epidemiology of conditions is difficult in the absence of clearly defined and agreed diagnostic criteria; it is also challenging for conditions that are uncommon and where clinical features are short-lived. Each of these three considerations applies to anaphylaxis, this to a large extent explaining why progress in describing the epidemiology of anaphylaxis has been so slow. But despite the inherent challenges in studying anaphylaxis, there have been a number of important studies published over the last decade, in particular from Europe, North America, and Australasia, which have employed a range of innovative methodological approaches to progressing understanding of this potentially fatal disorder. This paper will summarize some of the key studies conducted to-date, critically appraise their strengths and limitations, and reflect on the clinical implications of their findings.

Key references

  1. Sampson HA et al. JACI 2005; 115: 584-91
  2. Sampson HA et al. JACI 2006; 117: 391-97
  3. Pumphrey RSH. Clin Exp Aller 2000; 30: 1144-50
  4. International Collaborative Study of Severe Anaphylaxis.Epidemiology 1998; 9: 141-46
  5. Sheikh A, et al. BMJ 2000; 320: 1441
  6. Sheikh A, et al. Clin Exp Aller 2001; 31: 1571-76
  7. Ales B, et al. Arch Dis Child 2001; 85: 349
  8. Gupta R, et al. BMJ 2003; 327: 1142-43
  9. Stewart A et al. QJM 1996; 89: 859-64
  10. Smit DV et al. J Emer Med 2005; 28: 381-88
  11. Braganza SC et al. Arch Dis Child 2006; 91:159-63
  12. Helbling A, et al. Clin Exp Aller 2004;34:285-90
  13. Mullins RJ. Clin Exp Aller 2003; 33: 1033-40
  14. Bohlke K, et al. JACI 2004;113:536-42
  15. Peng MM et al. Arch Int Med 2004;164:317-19
  16. Simons FER et al. Ann Aller Asth Immunol 2001;86: 622-26
  17. Simons FER et al. JACI 2002; 110; 647-51.


Slide presentation

Return to top
Return to WAF: Vienna index